Ozempic, designed for type-2 diabetes treatment, has garnered widespread attention for its potential to aid weight loss in obese individuals. In Australia, where obesity affects 30% of the population, it has sparked significant interest and Novo Nordisk, the company behind it, has seen its share...

Weekly Wrap is a look at the week in news and what’s coming up. Hosted by the OG team of Claire Kimball and Kate Watson, it's s all about helping you stay on top of the news + we give you some talking points for the week ahead. Support News Club by signing up to our newsletter and following us on...